A citation-based method for searching scientific literature

Roberto Ferrari, Kim Fox. Nat Rev Cardiol 2016
Times Cited: 33







List of co-cited articles
102 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi. Lancet 2010
27

Ivabradine in stable coronary artery disease without clinical heart failure.
Kim Fox, Ian Ford, Philippe Gabriel Steg, Jean-Claude Tardif, Michal Tendera, Roberto Ferrari. N Engl J Med 2014
278
21

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.
Gilles Montalescot, Udo Sechtem, Stephan Achenbach, Felicita Andreotti, Chris Arden, Andrzej Budaj, Raffaele Bugiardini, Filippo Crea, Thomas Cuisset, Carlo Di Mario,[...]. Eur Heart J 2013
18


2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur J Heart Fail 2016
15


Vascular pathophysiology in response to increased heart rate.
Florian Custodis, Stephan H Schirmer, Magnus Baumhäkel, Gerd Heusch, Michael Böhm, Ulrich Laufs. J Am Coll Cardiol 2010
161
12

Heart rate and the cardiometabolic risk.
Paolo Palatini. Curr Hypertens Rep 2013
28
14



2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur Heart J 2016
9

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.
Michael Böhm, Karl Swedberg, Michel Komajda, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi. Lancet 2010
591
9

Heart rate and cardiovascular mortality: the Framingham Study.
W B Kannel, C Kannel, R S Paffenbarger, L A Cupples. Am Heart J 1987
936
9




Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link!
Mario Marzilli, C Noel Bairey Merz, William E Boden, Robert O Bonow, Paola G Capozza, William M Chilian, Anthony N DeMaria, Giacinta Guarini, Alda Huqi, Doralisa Morrone,[...]. J Am Coll Cardiol 2012
142
9

Medical treatment of stable angina: A tailored therapeutic approach.
Athanasios J Manolis, Leonidas E Poulimenos, Giuseppe Ambrosio, Manolis S Kallistratos, Jose Lopez-Sendon, Ralf Dechend, Giuseppe Mancia, A John Camm. Int J Cardiol 2016
26
11

Coronary microvascular dysfunction: an update.
Filippo Crea, Paolo G Camici, Cathleen Noel Bairey Merz. Eur Heart J 2014
343
9


Resting heart rate in cardiovascular disease.
Kim Fox, Jeffrey S Borer, A John Camm, Nicolas Danchin, Roberto Ferrari, Jose L Lopez Sendon, Philippe Gabriel Steg, Jean-Claude Tardif, Luigi Tavazzi, Michal Tendera. J Am Coll Cardiol 2007
638
9

Expert consensus document: A 'diamond' approach to personalized treatment of angina.
Roberto Ferrari, Paolo G Camici, Filippo Crea, Nicolas Danchin, Kim Fox, Aldo P Maggioni, Athanasios J Manolis, Mario Marzilli, Giuseppe M C Rosano, José L Lopez-Sendon. Nat Rev Cardiol 2018
62
9



Association of resting heart rate and its change with incident cardiovascular events in the middle-aged and older Chinese.
Jing Tian, Yu Yuan, Miaoyan Shen, Xiaomin Zhang, Meian He, Huan Guo, Handong Yang, Tangchun Wu. Sci Rep 2019
4
75

Impact of changes in heart rate with age on all-cause death and cardiovascular events in 50-year-old men from the general population.
Xiao-Jing Chen, Salim Bary Barywani, Per-Olof Hansson, Erik Östgärd Thunström, Annika Rosengren, Constantinos Ergatoudes, Zacharias Mandalenakis, Kenneth Caidahl, Michael Lx Fu. Open Heart 2019
14
21

Elevated resting heart rate, physical fitness and all-cause mortality: a 16-year follow-up in the Copenhagen Male Study.
Magnus Thorsten Jensen, Poul Suadicani, Hans Ole Hein, Finn Gyntelberg. Heart 2013
135
6



The Gln-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in Taiwan.
Y L Ko, Y S Ko, S M Wang, L A Hsu, C J Chang, P H Chu, N J Cheng, W J Chen, C W Chiang, Y S Lee. Atherosclerosis 1998
66
6

The relationship between paraoxonase1-192 polymorphism and activity with coronary artery disease.
Randa H Mohamed, Rasha H Mohamed, Rehab A Karam, Tarek A Abd El-Aziz. Clin Biochem 2010
37
6

Paraoxonase 1 gene polymorphisms in angiographically assessed coronary artery disease: evidence for gender interaction among Brazilians.
Domingos L S Rios, Lorenza O D'Onofrio, Caio C S Cerqueira, Ricardo Bonfim-Silva, Heitor G Carvalho, Ademar Santos-Filho, Bernardo Galvão-Castro. Clin Chem Lab Med 2007
24
8

Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases.
Y Imai, H Morita, H Kurihara, T Sugiyama, N Kato, A Ebihara, C Hamada, Y Kurihara, T Shindo, Y Oh-hashi,[...]. Atherosclerosis 2000
149
6

Association between PON1 activity and coronary heart disease risk: a meta-analysis based on 43 studies.
Yuan Zhao, Yushui Ma, Ying Fang, Lili Liu, Shengdi Wu, Da Fu, Xiaofeng Wang. Mol Genet Metab 2012
46
6


A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese.
T Zama, M Murata, Y Matsubara, K Kawano, N Aoki, H Yoshino, G Watanabe, K Ishikawa, Y Ikeda. Arterioscler Thromb Vasc Biol 1997
133
6

Paraoxonase 1 gene polymorphisms contribute to coronary artery disease risk among north Indians.
S Agrawal, Gaurav Tripathi, R Prajnya, Nakul Sinha, A Gilmour, L Bush, S Mastana. Indian J Med Sci 2009
22
9

R/R genotype of human paraoxonase (PON1) is more protective against lipoprotein oxidation and coronary artery disease in Japanese subjects.
Kenichi Kuremoto, Yoshiro Watanabe, Hirotoshi Ohmura, Kazunori Shimada, Hiroshi Mokuno, Hiroyuki Daida. J Atheroscler Thromb 2003
27
7

Paraoxonase Gln-Arg(192) and Leu-Met(55) gene polymorphisms and enzyme activity in a population with a low rate of coronary heart disease.
Natàlia Ferré, Mònica Tous, Antoni Paul, Alberto Zamora, Juan J Vendrell, Alfredo Bardají, Jordi Camps, Cristobal Richart, Jorge Joven. Clin Biochem 2002
35
6

The association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis.
Debbie A Lawlor, Ian N M Day, Tom R Gaunt, Lesley J Hinks, Patricia J Briggs, Matthew Kiessling, Nick Timpson, George Davey Smith, Shah Ebrahim. BMC Genet 2004
54
6

PON1 L55M polymorphism is not a predictor of coronary atherosclerosis either alone or in combination with Q192R polymorphism in an Italian population.
M Arca, D Ombres, A Montali, F Campagna, E Mangieri, G Tanzilli, P P Campa, G Ricci, R Verna, G Pannitteri. Eur J Clin Invest 2002
44
6

Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I.
Marie-Claude Blatter Garin, Xenia Moren, Richard W James. J Lipid Res 2006
62
6

Nutrition and Cardiovascular Disease: Finding the Perfect Recipe for Cardiovascular Health.
Alice Ravera, Valentina Carubelli, Edoardo Sciatti, Ivano Bonadei, Elio Gorga, Dario Cani, Enrico Vizzardi, Marco Metra, Carlo Lombardi. Nutrients 2016
34
6


Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials.
Ruairidh I R Martin, Oksana Pogoryelova, Mauro Santibáñez Koref, John P Bourke, M Dawn Teare, Bernard D Keavney. Heart 2014
91
6

Physiology and pharmacology of the cardiac pacemaker ("funny") current.
Mirko Baruscotti, Annalisa Bucchi, Dario Difrancesco. Pharmacol Ther 2005
214
6


Effect of Chronic Heart Rate Reduction by I(f) Current Inhibitor Ivabradine on Left Ventricular Remodeling and Systolic Performance in Middle-Aged Rats With Postmyocardial Infarction Heart Failure.
Eduard I Dedkov, Yevgen Bogatyryov, Daniela Scaldaferri McCooey, Lance P Christensen, Robert M Weiss, Robert J Tomanek. J Cardiovasc Pharmacol Ther 2015
6
33

EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot).
Aldo P Maggioni, Ulf Dahlström, Gerasimos Filippatos, Ovidiu Chioncel, Marisa Crespo Leiro, Jaroslaw Drozdz, Friedrich Fruhwald, Lars Gullestad, Damien Logeart, Gianna Fabbri,[...]. Eur J Heart Fail 2013
444
6

Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey.
Vincent M van Deursen, Renato Urso, Cecile Laroche, Kevin Damman, Ulf Dahlström, Luigi Tavazzi, Aldo P Maggioni, Adriaan A Voors. Eur J Heart Fail 2014
222
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.